N/A
Manufactured by ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI
107 FDA adverse event reports analyzed
Last updated: 2026-04-15
OCTINOXATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI. The most commonly reported adverse reactions for OCTINOXATE include DIVERTICULITIS, ANAPHYLACTIC REACTION, BRONCHIECTASIS, BURSITIS, DIVERTICULUM INTESTINAL. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for OCTINOXATE.
Out of 8 classified reports for OCTINOXATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 107 FDA FAERS reports that mention OCTINOXATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DIVERTICULITIS, ANAPHYLACTIC REACTION, BRONCHIECTASIS, BURSITIS, DIVERTICULUM INTESTINAL, HYPERSENSITIVITY. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list ALTONA COSMETICS TECHNOLOGY SANAYI VE TICARET ANONIM SIRKETI in connection with OCTINOXATE. Always verify the specific product and NDC with your pharmacist.